GlassScriptPhysician profile
Charles M Ware
NPI 1881689834
$2,123.75
in general payments reported to CMS, 2019-2025
24 companies · $84.58 in 2025
The $84.58 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $477 · 2021: $514 · 2022: $233 · 2023: $131 · 2024: $62.21 · 2025: $84.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $653.10 | 2019-2021 | |
| Stryker Corporation | $300.70 | 2019-2025 | Tornier Perform Reversed Glenoid, Variax |
| Fidia Pharma USA INC. | $210.78 | 2019-2024 | Hymovis, Triluron |
| Smith+Nephew, INC. | $205.38 | 2019-2022 | |
| Avanos Medical | $123.85 | 2019 | |
| Ferring Pharmaceuticals INC. | $87.47 | 2019-2022 | |
| Catalyst Orthoscience | $81.45 | 2021-2022 | |
| Pfizer INC. | $60.60 | 2020-2021 | |
| Wright Medical Technology, INC. | $45.28 | 2019 | |
| Ethicon US, LLC | $41.18 | 2020-2021 | |
| Orthofix Medical, INC. | $41.12 | 2021-2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $40.29 | 2020-2023 | Monovisc, Orthovisc |
| Dynasplint Systems INC. | $39.56 | 2021 | |
| Medacta USA, INC. | $25.41 | 2022 | |
| Assertio Therapeutics, INC. | $23.01 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $20.52 | 2024 | Nalu Neurostimulation System |
| Bioventus LLC | $20.49 | 2022 | |
| Linvatec Corporation | $20.40 | 2025 | Biobrace 23mm, Allograft Tissue |
| Sanara Medtech INC. | $18.30 | 2020 | |
| Abbott Laboratories | $15.89 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.32 | 2019 | |
| Paragon 28, INC. | $12.83 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $10.93 | 2019 | |
| Fx Shoulder Solutions, INC | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Ware listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.